I help cell & gene therapy and biopharma teams ship safer products faster — by combining hands-on quality and manufacturing operations with practical, audit-ready AI tooling.
Hands-on quality systems support for cell & gene therapy, viral vector, and biologics manufacturing — built for teams scaling from clinical to commercial.
Practical, validation-aware AI implementations for life sciences teams — agentic workflows, retrieval systems, and decision-support tools that respect the rules.
| 2024 — 2026 |
Vertex Pharmaceuticals
Quality Operations · Contract via Dexian
|
Cell Therapy |
| 2022 — 2024 |
Vor Biopharma
Manufacturing & Quality · CAR-T Operations
|
CAR-T / Engineered Hematology |
| 2021 — 2022 |
Bristol Myers Squibb
Cell Therapy Manufacturing
|
Commercial CAR-T |
| 2020 — 2021 |
Thermo Fisher Scientific
Viral Vector Production
|
Gene Therapy Supply |
I'm a biopharmaceutical quality and manufacturing professional with five-plus years inside cGMP environments — CAR-T, viral vectors, commercial cell therapy. I've authored deviations at 3am, sat through FDA inspections, and watched batch records become the nervous system of a clinical program.
I'm also a builder. I write Claude skills, ship side projects, and use AI tools daily — not as novelty, but as leverage. The interesting question for biotech right now isn't whether AI belongs in regulated environments. It's how we bring it in without breaking the trust that makes those environments work.
That intersection is where I want to spend my time. If you're a Portland-area biotech, a cell or gene therapy team, or a quality org wondering where AI fits — let's talk.